Movement Alert|Axon Enterprise Rises 5.42% in Regular Trading, RBC Reaffirms 30%+ Revenue Growth Outlook with $735 Target

Market Focus
Jul 01

On July 1, Axon Enterprise rose 5.42% in regular trading, trading at $591.87 per share with turnover of $2.23 billion, extending its recent strong upward momentum.

On the news front, RBC Capital Markets reiterated its bullish stance on Axon Enterprise, noting the company is well-positioned to sustain revenue growth exceeding 30% by leveraging technology aimed at more effective policing. Analysts highlighted multiple growth opportunities from the convergence of AI adoption, an open ecosystem strategy, and an expanding portfolio of AI solutions. RBC emphasized that as police departments face staffing shortages and budget pressures, Axon's technology will become increasingly critical, driving continued market share gains. The firm maintained its outperform rating and $735 price target, implying approximately 24% upside from current levels.

Fundamentally, Axon reported Q1 revenue of $807.35 million, surpassing consensus estimates of $778.9 million, and raised its full-year revenue growth guidance to 30%-32%, up from the prior 27%-30% range. The company has also set a longer-term target of approximately $6 billion in annual revenue by 2028 with 28% adjusted EBITDA margins.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10